Literature DB >> 26634028

ANA-Negative Lupus Presenting with Heart Failure and Severe Valvular Dysfunction: Case Report and Review of the Literature.

Vu Hoang1, Daniel Addison1, Nasser Lakkis1, Rashed Tabbaa1.   

Abstract

Antinuclear antibody (ANA) negative lupus is an important subset of the systemic lupus erythematosus (SLE) disease spectrum. Since the introduction of human cell line for ANA assay, the occurrence of true ANA-negative SLE has been a rare clinical phenomenon. The nature of cardiac involvement in ANA-negative SLE is not well understood, although any cardiac involvement, including valvular dysfunction, should be considered as a presenting manifestation of SLE irrespective of serology status. Early recognition and intervention appears to be associated with decreased morbidity. The following report describes our first case of ANA-negative SLE with an initial presentation of severe cardiac valvular dysfunction and heart failure. It also characterizes the spectrum of disease severity in ANA-negative SLE and demonstrates how aggressive SLE therapy can improve cardiac disease.

Entities:  

Keywords:  ANA-negative lupus; heart failure; valvular dysfunction

Mesh:

Substances:

Year:  2015        PMID: 26634028      PMCID: PMC4666427          DOI: 10.14797/mdcj-11-3-186

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN: 1947-6108


  10 in total

Review 1.  Antinuclear antibody-negative lupus as a distinct diagnostic entity--does it no longer exist?

Authors:  L S Cross; A Aslam; S A Misbah
Journal:  QJM       Date:  2004-05

2.  Ro 52kD autoantibodies are detected in a subset of ANA-negative sera.

Authors:  N Pourmand; S Blomberg; L Rönnblom; A Karlsson-Parra; I Pettersson; M Wahren-Herlenius
Journal:  Scand J Rheumatol       Date:  2000       Impact factor: 3.641

3.  Seronegative systemic lupus erythematosus.

Authors:  A Bohan
Journal:  J Rheumatol       Date:  1979 Sep-Oct       Impact factor: 4.666

Review 4.  Cardiac involvement in systemic lupus erythematosus.

Authors:  K G Moder; T D Miller; H D Tazelaar
Journal:  Mayo Clin Proc       Date:  1999-03       Impact factor: 7.616

5.  ANA negative systemic lupus erythematosus sera revisited serologically.

Authors:  M Reichlin
Journal:  Lupus       Date:  2000       Impact factor: 2.911

6.  Serological findings in patients with "ANA-negative" systemic lupus erythematosus.

Authors:  P J Maddison; T T Provost; M Reichlin
Journal:  Medicine (Baltimore)       Date:  1981-03       Impact factor: 1.889

Review 7.  Valvular heart disease and systemic lupus erythematosus: therapeutic implications.

Authors:  Adrian Fluture; Shobhana Chaudhari; William H Frishman
Journal:  Heart Dis       Date:  2003 Sep-Oct

Review 8.  Systemic lupus erythematosus. Recognizing its various presentations.

Authors:  J M Von Feldt
Journal:  Postgrad Med       Date:  1995-04       Impact factor: 3.840

9.  Prevalence, morphologic types, and evolution of cardiac valvular disease in systemic lupus erythematosus.

Authors:  E Galve; J Candell-Riera; C Pigrau; G Permanyer-Miralda; H Garcia-Del-Castillo; J Soler-Soler
Journal:  N Engl J Med       Date:  1988-09-29       Impact factor: 91.245

10.  Cardiac valve replacement in systemic lupus erythematosus. A review.

Authors:  H Dajee; E J Hurley; R J Szarnicki
Journal:  J Thorac Cardiovasc Surg       Date:  1983-05       Impact factor: 5.209

  10 in total
  2 in total

1.  Systemic Lupus Erythematosus Presenting as Myopericarditis with Acute Heart Failure: A Case Report and Literature Review.

Authors:  Richard Jesse Durrance; Malahat Movahedian; Worku Haile; Katerina Teller; Richard Pinsker
Journal:  Case Rep Rheumatol       Date:  2019-07-24

2.  Comparison of the sensitivity of the EULAR / ACR 2019 and SLICC 2012 classification criteria in a Colombian population with systemic lupus erythematosus.

Authors:  Diana Guavita-Navarro; Laura Gallego-Cardona; Ana María Arredondo; Hector Cubides; Jairo Cajamarca-Barón; Claudia Ibáñez; Alejandro Escobar; Adriana Rojas-Villarraga
Journal:  J Transl Autoimmun       Date:  2021-11-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.